Semeta™ offers high sensitivity and superior precision for the prediction of Phase I and II metabolic routes, sites, products and liabilities in early drug discovery CAMBRIDGE, UK – Optibrium, a leading developer of software and AI solutions for drug discovery, today announced the launch of Semeta™, a metabolism prediction platform tailored specifically for drug metabolism [...]

QIAGEN Biomedical KB-AI contains over 640 million biomedical relationships, including gene, disease and drug causal relationships, to aid in data-driven drug discovery AI-driven insights complement human-curated QIAGEN Biomedical KB-HD and help identify novel relationships between diseases, biological pathways and molecular interactions that may be missed by traditional methods Workflow cuts down on hypothesis testing time and speeds [...]

Financing led by Sands Capital brings total capital raised to nearly $250 million. Fremont, CA, US – Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, announced today the first close of $100 million in Series C financing with the second close of an additional $28 million expected to happen within [...]

SHANGHAI - On February 26, 2024, Illumina Inc. (NASDAQ: ILMN) a global leader in DNA sequencing and array-based technologies, announced that Jenny Zheng joins Illumina as Senior Vice President and General Manager of Greater China, and a member of the global executive management team, effective from February 26. Ms. Zheng has more than 25 years of international experience in healthcare and pharmaceutical [...]

Tewksbury, Mass. News: Thermo Fisher Scientific has announced the release of the new TruScan G3 Handheld Raman Analyzer, enabling rapid raw material identification for the small and large molecule pharmaceutical sectors. Overview: Thermo Fisher is proud to introduce the new Thermo ScientificTM TruScanTM G3 Handheld Raman Analyzer, offering next generation raw material identification for the [...]

The collaboration will develop and distribute a multi-chambered cardiac organoid model that accurately mimics human physiology for applications in cardiac toxicology testing and drug development MANASSAS, Va. & TEL AVIV, Israel -- ATCC, the world’s premier biological materials management and standards organization, and Tissue Dynamics, a disruptive pharma-tech company integrating advanced artificial intelligence tools with bionic [...]

Rapid, Sensitive, and Validated Detection of Viral Replication Genes Using Droplet Digital™ PCR During Cell and Gene Therapy Production HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the recent launch of the Vericheck ddPCR™ Replication Competent Lentivirus Kit and the Vericheck [...]

Fastest stabilization time in its class for analytical weighing; results in under 2 seconds Low minimum sample weight starting at 4.1 mg sets new benchmark for semi-microbalances Innovative Cleaning QApp and tool-free assembly simplify compliance and routine maintenance Advanced ionizing technology fully eliminates static electricity, optimizing accuracy Göttingen -- The Life Science Group Sartorius introduces [...]

High Purity New England is excited to be partnering with Constant Systems, expanding their product offerings to include three new innovative Cell Disruptors. Smithfield, RI, USA - A leader in the biopharma industry for designing and supplying custom solutions and equipment, High Purity New England (HPNE) is thrilled to be partnering with Constant Systems for the distribution [...]

Funding through Government of Canada's Regional Quantum Initiative supports product development and commercialization efforts WATERLOO, ON - High Q Technologies Inc., an innovative life sciences company that develops quantum-enabled scientific instruments for protein characterization in drug discovery, announces a $3.75-million Government of Canada investment, through the Federal Economic Development Agency for Southern Ontario (FedDev Ontario), as part of the Regional Quantum Initiative. The funding will support [...]